tradingkey.logo
tradingkey.logo
Search

Beam Therapeutics Inc

BEAM
Add to Watchlist
25.520USD
-0.970-3.66%
Close 07-31 16:00ETQuotes delayed by 15 min
2.63BMarket Cap
LossP/E TTM

Institutional Confidence

Currency: USD Updated: 2026-07-31
Previous score
10.00
Change
0
The current institutional shareholding score of Beam Therapeutics Inc is 10.00, ranking 1 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 103.20%, representing a quarter-over-quarter decrease of 9.85%. The largest institutional shareholder is Catherine Wood, holding a total of 9.07M shares, representing 12.21% of shares outstanding, with 3.53% increase in holdings.

Institutional Shareholding

Shareholder Activity

Name
Shares Held
Chg %
ARK Investment Management LLC
Star Investors
12.47M
+12.94%
Fidelity Management & Research Company LLC
11.40M
+1.13%
Farallon Capital Management, L.L.C.
10.06M
--
BlackRock Institutional Trust Company, N.A.
6.99M
+3.18%
State Street Investment Management (US)
5.23M
+30.43%
ARCH Venture Partners
4.54M
--
Amova Asset Management Co., Ltd.
4.41M
-8.72%
T. Rowe Price Associates, Inc.
Star Investors
2.60M
+20.04%
1
2
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.